雋思集團(01412.HK):上半年純利5400萬港元 同比增加50.9% 中期息每股3港仙
格隆匯8月23日丨雋思集團(01412.HK)發佈公吿,2024年首六個月,集團的總收益約為5.39億港元,同比增加約16.9%;公司權益股東應占溢利約為5400萬港元,同比增加約50.9%;每股基本盈利約為10.15港仙。董事會決議宣派2024年首六個月的中期股息每股普通股3.0港仙。
2024年首六個月,集團的毛利約為1.93億港元,同比增加約25.1%。毛利率由2023年首六個月的約33.4%增加至2024年首六個月的約35.7%。該增加主要由於OEM銷售及網站銷售收益增加帶來更佳規模經濟效益以及營運和生產效率持續提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.